These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34070642)

  • 41. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules.
    Calogiuri G; Nettis E; Di Leo E; Foti C; Ferrannini A; Butani L
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):19-28. PubMed ID: 23092365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
    J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a novel alkaline Arxula adeninivorans urate oxidase expressed in Escherichia coli and its application in reducing uric acid content of food.
    Zhang R; Gao SJ; Zhu CY; Sun Y; Liu XL; Zhao MM; Wang CH
    Food Chem; 2019 Sep; 293():254-262. PubMed ID: 31151609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermostable lipases from extremely radioresistant bacterium Deinococcus radiodurans: cloning, expression, and biochemical characterization.
    Shao H; Xu L; Yan Y
    J Basic Microbiol; 2014 Sep; 54(9):984-95. PubMed ID: 24002979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pegloticase and lowering blood pressure in refractory gout; is it uric acid or hydrogen peroxide?
    Fini MA; Stenmark KR
    Eur J Intern Med; 2019 Nov; 69():e11-e12. PubMed ID: 31471165
    [No Abstract]   [Full Text] [Related]  

  • 48. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.
    Tan PK; Farrar JE; Gaucher EA; Miner JN
    Mol Biol Evol; 2016 Sep; 33(9):2193-200. PubMed ID: 27352852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperuricemia and gout: new insights into pathogenesis and treatment.
    Pillinger MH; Rosenthal P; Abeles AM
    Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 51. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 52. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expert opinion on emerging urate-lowering therapies.
    Stamp LK; Merriman TR; Singh JA
    Expert Opin Emerg Drugs; 2018 Sep; 23(3):201-209. PubMed ID: 30244605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy.
    Pession A; Barbieri E; Santoro N; Paolucci P; Porta F; Locatelli F
    Haematologica; 2005 Jan; 90(1):141-2. PubMed ID: 15642687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid.
    Liu S; Perez-Ruiz F; Miner JN
    Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical characterization of two DNA ligases from Deinococcus radiodurans.
    Le D; Hua X; Huang L; Gao G; Lu H; Xu Z; Tian B; Hua Y
    Protein Pept Lett; 2008; 15(6):600-5. PubMed ID: 18680457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.
    Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL
    Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Resurrected" human-source urate oxidase with high uricolytic activity and stability.
    Jiang N; Xu C; Zhang L; Chen J
    Enzyme Microb Technol; 2021 Sep; 149():109852. PubMed ID: 34311889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of hyperuricemia with rasburicase review.
    de Bont JM; Pieters R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.